VITL, the operating system for cash-pay health, announced the close of its $7.5 million Series A funding round led by ...
Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, is proud to announce that its IdentiClone Dx IGH Assay has received In Vitro Diagnostic Regulation ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果